85 results
Page 4 of 5
8-K
EX-3.1
ucxtldfyj
18 Sep 19
Unregistered Sales of Equity Securities
9:40pm
S-8
6u0jgberzfaq
7 Aug 19
Registration of securities for employees
5:31pm
8-K/A
9uyuql dgbqs
28 Mar 19
Ovid Therapeutics Announces Senior Management Changes to Align Expertise with Advancing Clinical Stage Pipeline
12:27pm
424B5
5ty3c q656sa7
21 Feb 19
Prospectus supplement for primary offering
9:24pm
424B5
c91milby
21 Feb 19
Prospectus supplement for primary offering
9:22pm
8-K
EX-3.1
hq47cqv43
21 Feb 19
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
4:53pm
8-K
EX-1.1
1ga w2e5nx99h
21 Feb 19
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
4:53pm
8-K
EX-1.2
0wxmrr3bsgqho3yot 8q
21 Feb 19
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
4:53pm
424B5
lzh504
19 Feb 19
Prospectus supplement for primary offering
4:06pm
424B5
yho 3jm0rzr
19 Feb 19
Prospectus supplement for primary offering
4:04pm
S-3
EX-4.7
k5wawuko0
1 Jun 18
Shelf registration
5:14pm
S-3
1airvy8u 5kv
1 Jun 18
Shelf registration
5:14pm
S-3
EX-4.4
2ut58 4i4xg8
1 Jun 18
Shelf registration
5:14pm
S-3
EX-4.8
5bzt3 8snt
1 Jun 18
Shelf registration
5:14pm
S-3
EX-4.6
d9ywpa7ozm
1 Jun 18
Shelf registration
5:14pm
S-3
EX-1.2
bo25hs rba25yc
1 Jun 18
Shelf registration
5:14pm